Optiver Holding
ENTA icon

Optiver Holding’s Enanta Pharmaceuticals ENTA Stock Holding History

Optiver Holding’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.41K Sell
234
-24
-9% -$323 ﹤0.01% 2132
2026
Q1 		$3.26K Hold
258
– – ﹤0.01% 1618
2025
Q4 		$4.07K Hold
258
– – ﹤0.01% 1518
2025
Q3 		$3.09K Buy
+258
New +$2.06K ﹤0.01% 2167

Other funds holding ENTA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Optiver Holding's ENTA Position: Q2 2026 in Review

Optiver Holding reduced its Enanta Pharmaceuticals (ENTA) stake by 9.3% in Q2 2026, selling an estimated $323 and leaving 234 shares worth $3.41K. The position accounts for ﹤0.01% of the portfolio, ranked #2132.

Optiver Holding first reported a position in ENTA in Q3 2025 and has held it in 4 quarters since. The position peaked at $4.07K in Q4 2025. 123 funds tracked by Wall St. Rank hold ENTA as of Q2 2026.

  • Optiver Holding held 234 shares of Enanta Pharmaceuticals worth $3.41K as of Q2 2026.
  • Optiver Holding sold 24 Enanta Pharmaceuticals shares in Q2 2026, an estimated $323.
  • Enanta Pharmaceuticals made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2132 holding.
  • Optiver Holding first reported a position in Enanta Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Enanta Pharmaceuticals position peaked at $4.07K in Q4 2025.
  • 123 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.